
Kisspeptin Peptide: What Human Trials Show About HPG Axis
Kisspeptin peptide switches on the brain's reproductive axis. See what human trials actually show about LH timing, testosterone, and dosing limits.
Research-backed articles on peptides, protocols, and longevity science.
Every post on this blog is built around a single rule: the load-bearing claim has to point at a peer-reviewed source. The catalog spans five clusters: the GH-axis (CJC-1295, ipamorelin, tesamorelin, MK-677), the GLP-1 class (semaglutide, tirzepatide, retatrutide, cagrilintide), tissue healing (BPC-157, TB-500, GHK-Cu, KPV), cognitive peptides (semax, selank, dihexa), and longevity (NAD+, epitalon, DSIP, thymosin alpha-1). Pieces are reviewed against PubMed, ClinicalTrials.gov, FDA, EMA, Helsedirektoratet, FHI, and Legemiddelverket. We hedge claims the literature hedges and we name the gaps where the human-trial database is still light.
GHRH analogues and GH-releasing peptides for body composition, recovery, and the IGF-1 lever. CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677, GHRP-2 and GHRP-6.
Read the guide: The GH peptide axisIncretin-receptor agonists for weight management and metabolic disease. Semaglutide, tirzepatide, retatrutide, cagrilintide, liraglutide. Class explainers, head-to-head comparisons, FDA label dosing and the compounding picture.
Read the guide: Peptides for weight lossPeptides studied for tissue repair, gut barrier, and inflammation. BPC-157, TB-500, GHK-Cu, KPV, and the stacking question the research community keeps returning to.
Read the guide: Peptides for healingCompounds with evidence for attention, mood, and neuroplasticity. Semax, selank, dihexa, cerebrolysin. Includes the where-the-data-runs-out caveats.
Read the guide: Cognitive peptidesCompounds in the longevity and metabolic-health corner of the catalog. NAD+, epitalon, DSIP, thymosin alpha-1, plus the regulatory framing each one currently sits in.
Read the guide: Peptides for longevityEach guide opens with a Key Takeaways box that summarizes the load-bearing claims in 3 to 5 bullets. The body always moves mechanism, evidence, dosing, then risk profile, and states FDA status plainly. Reviewer date and credentials sit in the byline of every post. If you are new to peptide research, start with What are peptides used for and What is peptide therapy before the deeper protocol guides.
Each guide covers one goal or peptide class end to end and links out to the detailed posts behind it.

Kisspeptin peptide switches on the brain's reproductive axis. See what human trials actually show about LH timing, testosterone, and dosing limits.

LL-37 peptide kills bacteria by rupturing membranes, but human evidence stops at topical ulcer trials and one gene-therapy study, not injections.

Peptides for inflammation compared by mechanism and evidence stage: BPC-157, KPV, thymosin alpha-1, and thymosin beta-4, with FDA status and safety notes.

Mounjaro and Zepbound are the same drug, tirzepatide, at the same doses. The difference is the FDA label: diabetes for Mounjaro, weight loss for Zepbound.

Rybelsus is not FDA-approved for weight loss and moves the scale only a little. The oral semaglutide approved for weight loss is the Wegovy pill at 25 mg.

The Wegovy pill is semaglutide 25 mg taken daily, FDA-approved for weight loss in December 2025. How to take it, how well it works, and how it compares.

5-Amino-1MQ is sold for fat loss, but every published result is preclinical. Read the NNMT mechanism, the circulating dosing range, and its FDA status.

Men search peptides for seven goals: muscle, fat loss, libido, hormones, recovery, hair, longevity. Here is the FDA status and trial evidence behind each.

Most peptide trials enrolled mostly men. This guide sorts every compound by whether women were actually studied, from PT-141 and GLP-1s to BPC-157.

Most peptides for testosterone act on the growth hormone axis and never touch LH. Here is which compounds have measured serum testosterone in men.

Ozempic tablets, Rybelsus and Wegovy tablets are all semaglutide, and three strengths appear on two different products. Here is which is which.

The oral Wegovy ladder runs 1.5 to 25 mg daily; the standard injection ladder runs 0.25 to 2.4 mg weekly. Same molecule, different scale, often conflated.
Science·August 21, 2026·8 min read
Science·August 21, 2026·9 min read
Safety·August 19, 2026·13 min read
Safety·August 18, 2026·12 min read
Peptide guide·August 13, 2026·11 min read
Comparison·August 12, 2026·15 min read
Comparison·August 6, 2026·13 min read
Protocol·July 30, 2026·12 min read
Protocol·July 30, 2026·13 min read
Comparison·July 24, 2026·12 min read
Protocol·July 20, 2026·11 min read
Comparison·July 18, 2026·12 min read
Safety·July 17, 2026·14 min read
Comparison·July 16, 2026·13 min read
Safety·July 15, 2026·11 min read
Comparison·July 14, 2026·13 min read
Peptide guide·July 13, 2026·12 min read
Comparison·July 11, 2026·15 min read
Peptide guide·July 10, 2026·12 min read
Comparison·July 9, 2026·15 min read
Science·July 8, 2026·14 min read
Comparison·July 7, 2026·13 min read
Peptide guide·July 6, 2026·12 min read
Comparison·July 4, 2026·12 min read
Peptide guide·July 3, 2026·12 min read
Comparison·July 2, 2026·15 min read
Science·July 1, 2026·13 min read
Comparison·June 30, 2026·14 min read
Science·June 29, 2026·12 min read
Comparison·June 27, 2026·14 min read
Peptide guide·June 25, 2026·11 min read
Science·June 24, 2026·12 min read
Peptide guide·June 24, 2026·13 min read
Peptide guide·June 23, 2026·12 min read
Comparison·June 23, 2026·15 min read
Peptide guide·June 22, 2026·13 min read
Comparison·June 20, 2026·14 min read
Comparison·June 19, 2026·14 min read
Comparison·June 18, 2026·13 min read
Science·June 17, 2026·14 min read
Comparison·June 16, 2026·14 min read
Peptide guide·June 15, 2026·12 min read
Comparison·June 13, 2026·12 min read
Peptide guide·June 12, 2026·14 min read
Comparison·June 11, 2026·14 min read
Peptide guide·June 10, 2026·15 min read
Comparison·June 9, 2026·14 min read
Peptide guide·June 8, 2026·14 min read
Safety·June 6, 2026·14 min read
Comparison·June 6, 2026·13 min read
Comparison·June 4, 2026·17 min read
Science·June 3, 2026·14 min read
Comparison·June 2, 2026·16 min read
Peptide guide·June 1, 2026·14 min read
Comparison·May 30, 2026·14 min read
Safety·May 29, 2026·16 min read
Comparison·May 28, 2026·14 min read
Comparison·May 28, 2026·12 min read
Safety·May 26, 2026·15 min read
Comparison·May 26, 2026·16 min read
Comparison·May 26, 2026·15 min read
Peptide guide·May 25, 2026·12 min read
Safety·May 24, 2026·14 min read
Comparison·May 23, 2026·15 min read
Peptide guide·May 23, 2026·13 min read
Protocol·May 22, 2026·14 min read
Safety·May 21, 2026·12 min read
Comparison·May 21, 2026·15 min read
Peptide guide·May 20, 2026·18 min read
Comparison·May 19, 2026·14 min read
Peptide guide·May 19, 2026·14 min read
Comparison·May 18, 2026·13 min read
Science·May 18, 2026·18 min read
Protocol·May 18, 2026·11 min read
Comparison·May 18, 2026·19 min read
Comparison·May 16, 2026·12 min read
Comparison·May 16, 2026·15 min read
Comparison·May 15, 2026·15 min read
Comparison·May 14, 2026·13 min read
Peptide guide·May 14, 2026·17 min read
Safety·May 13, 2026·13 min read
Science·May 12, 2026·14 min read
Peptide guide·May 11, 2026·17 min read
Comparison·May 11, 2026·14 min read
Peptide guide·May 10, 2026·13 min read
Peptide guide·May 9, 2026·17 min read
Peptide guide·May 8, 2026·14 min read
Protocol·May 7, 2026·19 min read
Science·May 5, 2026·20 min read
Peptide guide·April 28, 2026·17 min read
Peptide guide·April 28, 2026·19 min read
Peptide guide·April 28, 2026·26 min read
Peptide guide·April 25, 2026·17 min read
Peptide guide·April 25, 2026·17 min read
Safety·April 24, 2026·19 min read
Peptide guide·April 22, 2026·27 min read
Protocol·April 20, 2026·10 min read
Peptide guide·April 20, 2026·14 min read
Protocol·April 20, 2026·13 min read
Comparison·April 20, 2026·12 min read
Peptide guide·April 20, 2026·11 min read
Peptide guide·April 20, 2026·9 min read
Peptide guide·April 20, 2026·12 min read
Science·April 20, 2026·12 min read
Protocol·April 20, 2026·11 min read
Peptide guide·April 20, 2026·10 min read
Peptide guide·April 20, 2026·8 min read
Peptide guide·April 20, 2026·12 min read
Safety·April 20, 2026·12 min read
Protocol·April 20, 2026·10 min read
Peptide guide·April 20, 2026·19 min read
Peptide guide·April 20, 2026·11 min read
Comparison·April 20, 2026·12 min read
Peptide guide·April 20, 2026·15 min read
Peptide guide·April 20, 2026·11 min read
Peptide guide·April 20, 2026·20 min read